Revised Cardiac Risk Index

Last updated


The Revised Cardiac Risk Index (RCRI) is a tool used to estimate a patient's risk of perioperative cardiac complications. The RCRI and similar clinical prediction tools are derived by looking for an association between preoperative variables (e.g., patient's age, type of surgery, comorbid diagnoses, or laboratory data) and the risk for cardiac complications in a cohort of surgical patients (the "derivation cohort"). Variables that have independent predictive value in a logistic regression analysis are incorporated into the risk index. Ideally, the accuracy and validity of the risk index is then tested in a separate cohort (the "validation cohort"). In 1977 Goldman, et al., developed the first cardiac risk index, which included nine variables associated with an increased risk of perioperative cardiac complications. [1] This became known as the Original Cardiac Risk Index (or alternatively the Goldman Index). In 1999, Lee et al. published a cardiac risk index derived from 2893 patients and validated in 1422 patients aged ≥ 50 undergoing major noncardiac surgery, which became known as the Revised Cardiac Risk Index (RCRI). [2] Lee identified six independent variables that predicted an increased risk for cardiac complications. A patient's risk for perioperative cardiac complications increased with number of variables that were present.

Contents

Revised Cardiac Risk Index
1. History of ischemic heart disease
2. History of congestive heart failure
3. History of cerebrovascular disease (stroke or transient ischemic attack)
4. History of diabetes requiring preoperative insulin use
5. Chronic kidney disease [creatinine > 2 mg/dL (176.8 μmol/L)]
6. Undergoing suprainguinal vascular, intraperitoneal, or intrathoracic surgery
Risk for cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest:

0 predictors = 3.9%, 1 predictor = 6.0%, 2 predictors = 10.1%, ≥3 predictors = 15% (Duceppe 2017)

Compared with the Original Cardiac Risk Index, the RCRI was easier to use and more accurate. The RCRI was used widely in clinical practice, research, and was incorporated in a modified form into the 2007 preoperative cardiac risk evaluation guideline from the American Heart Association and American College of Cardiology. [3] The ACC/AHA guidelines use the 5 clinical RCRI criteria in their screening algorithm. The surgery-specific risk (#6 on the above list) is included separately in the algorithm. Criterion #4, diabetes with insulin use was also changed to any diagnosis of diabetes in the ACC/AHA algorithm.

2014 ACC/AHA Perioperative Guidelines stated that two newer tools have been created by the American College of Surgeons, which prospectively collected data on operations performed in more than 252 participating hospitals in the United States. Data on more than 1 million operations have been used to create these risk calculators. This tool includes adjusted ORs for different surgical sites, with inguinal hernia as the reference group. Target complications were defined as cardiac arrest (defined as "chaotic cardiac rhythm requiring initiation of basic or advanced life support") or MI (defined as ≥1 of the following: documented electrocardiographic findings of MI, ST elevation of ≥1 mm in >1 contiguous leads, new left bundle-branch block, new Q-wave in ≥2 contiguous leads, or troponin >3 times normal in setting of suspected ischemia). [4]

Alternatives

In 2022, Onishchenko et al. published the Cardiac Comorbidity Risk (CCoR) score for assessing the risk of major adverse cardiac events (MACE) after hip and knee arthroplasty surgeries, that claimed to supersede the RCRI in predictive performance. [5] Unlike the RCRI, the CCoR mines the history of medical encounters to identify subtle comorbidity signatures that increase the risk of cardiac events, and was claimed to reliably assess "low-risk" patients, e.g., ones with none of the risk factors that RCRI uses.

See also

Related Research Articles

<span class="mw-page-title-main">Coronary artery disease</span> Disease characterized by plaque building up in the arteries of the heart

Coronary artery disease (CAD), also called coronary heart disease (CHD), ischemic heart disease (IHD), myocardial ischemia, or simply heart disease, involves the reduction of blood flow to the heart muscle due to build-up of atherosclerotic plaque in the arteries of the heart. It is the most common of the cardiovascular diseases. Types include stable angina, unstable angina, myocardial infarction, and sudden cardiac death. A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest. Shortness of breath may also occur and sometimes no symptoms are present. In many cases, the first sign is a heart attack. Other complications include heart failure or an abnormal heartbeat.

An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation. They are effective in the arterial circulation where anticoagulants have little effect.

<span class="mw-page-title-main">Heart failure</span> Failure of the heart to provide sufficient blood flow

Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome, a group of signs and symptoms caused by an impairment of the heart's blood pumping function. Symptoms typically include shortness of breath, excessive fatigue, and leg swelling. The shortness of breath may occur with exertion or while lying down, and may wake people up during the night. Chest pain, including angina, is not usually caused by heart failure, but may occur if the heart failure was caused by a heart attack. The severity of the heart failure is measured by the severity of symptoms during exercise. Other conditions that may have symptoms similar to heart failure include obesity, kidney failure, liver disease, anemia, and thyroid disease.

<span class="mw-page-title-main">Aortic regurgitation</span> Medical condition

Aortic regurgitation (AR), also known as aortic insufficiency (AI), is the leaking of the aortic valve of the heart that causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle. As a consequence, the cardiac muscle is forced to work harder than normal.

Aortic valve replacement is a procedure whereby the failing aortic valve of a patient's heart is replaced with an artificial heart valve. The aortic valve may need to be replaced because:

<span class="mw-page-title-main">Pneumonectomy</span> Surgical removal of a lung

A pneumonectomy is a surgical procedure to remove a lung first successfully done in 1933 by Dr. Evarts Graham. This is not to be confused with a lobectomy or segmentectomy, which only removes one part of the lung.

A post-anesthesia care unit, often abbreviated PACU and sometimes referred to as post-anesthesia recovery or PAR, or simply Recovery, is a vital part of hospitals, ambulatory care centers, and other medical facilities. Patients who received general anesthesia, regional anesthesia, or local anesthesia are transferred from the operating room suites to the recovery area. The patients are monitored typically by anesthesiologists, certified registered nurse anesthetists, and other medical staff. Providers follow a standardized handoff to the medical PACU staff that includes, which medications were given in the operating room suites, how hemodynamics were during the procedures, and what is expected for their recovery. After initial assessment and stabilization, patients are monitored for any potential complications, until the patient is transferred back to their hospital rooms.

<span class="mw-page-title-main">Hypertensive heart disease</span> Medical condition

Hypertensive heart disease includes a number of complications of high blood pressure that affect the heart. While there are several definitions of hypertensive heart disease in the medical literature, the term is most widely used in the context of the International Classification of Diseases (ICD) coding categories. The definition includes heart failure and other cardiac complications of hypertension when a causal relationship between the heart disease and hypertension is stated or implied on the death certificate. In 2013 hypertensive heart disease resulted in 1.07 million deaths as compared with 630,000 deaths in 1990.

Postoperative cognitive dysfunction (POCD) is a decline in cognitive function that may last from 1–12 months after surgery, or longer. In some cases, this disorder may persist for several years after major surgery. POCD is distinct from emergence delirium. Its causes are under investigation and occurs commonly in older patients and those with pre-existing cognitive impairment.

The history of invasive and interventional cardiology is complex, with multiple groups working independently on similar technologies. Invasive and interventional cardiology is currently closely associated with cardiologists, though the development and most of its early research and procedures were performed by diagnostic and interventional radiologists.

The Canadian Cardiovascular Society (CCS) is the national voice for cardiovascular physicians and scientists in Canada. The CCS is a membership organization that represents more than 1,800 professionals in the cardiovascular field. Its mission is to promote cardiovascular health and care through knowledge translation, professional development and leadership in health policy.

The Outcomes Research Consortium is an international clinical research group that focuses on the perioperative period, along with critical care and pain management. The Consortium's aim is to improve the quality of care for surgical, critical care, and chronic pain patients and to "Provide the evidence for evidence-based practice." Members of the Consortium are especially interested in testing simple, low-risk, and inexpensive treatments that have the potential to markedly improve patients' surgical experiences.

<span class="mw-page-title-main">Atrial fibrillation</span> Rapid, irregular beating of the atria of the heart

Atrial fibrillation is an abnormal heart rhythm (arrhythmia) characterized by rapid and irregular beating of the atrial chambers of the heart. It often begins as short periods of abnormal beating, which become longer or continuous over time. It may also start as other forms of arrhythmia such as atrial flutter that then transform into AF. Episodes can be asymptomatic. Symptomatic episodes may involve heart palpitations, fainting, lightheadedness, shortness of breath, or chest pain. Atrial fibrillation is associated with an increased risk of heart failure, dementia, and stroke. It is a type of supraventricular tachycardia.


A wearable cardioverter defibrillator (WCD) is a non-invasive, external device for patients at risk of sudden cardiac arrest (SCA). It allows physicians time to assess their patient's arrhythmic risk and make appropriate plans. It is a leased device. A summary of the device, its technology and indications was published in 2017 and reviewed by the EHRA Scientific Documents Committee.

Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.

<span class="mw-page-title-main">Cardiac imaging</span>

Cardiac imaging refers to non-invasive imaging of the heart using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT. These cardiac techniques are otherwise referred to as echocardiography, Cardiac MRI, Cardiac CT, Cardiac PET and Cardiac SPECT including myocardial perfusion imaging.

<span class="mw-page-title-main">Hybrid cardiac surgery</span>

A hybrid cardiac surgical procedure in a narrow sense is defined as a procedure that combines a conventional, more invasive surgical part with an interventional part, using some sort of catheter-based procedure guided by fluoroscopy imaging in a hybrid operating room (OR) without interruption. The hybrid technique has a reduced risk of surgical complications and has shown decreased recovery time. It can be used to treat numerous heart diseases and conditions and with the increasing complexity of each case, the hybrid surgical technique is becoming more common.

The Society for Vascular Medicine is a United States-based medical specialty professional society in the field of vascular medicine. Vascular medicine is a subspecialty of internal medicine or of Cardiology. It was founded in 1989.

Preoperative care refers to health care provided before a surgical operation. The aim of preoperative care is to do whatever is right to increase the success of the surgery.

<span class="mw-page-title-main">Lee Goldman</span> American cardiologist and educator

Lee Goldman is an American cardiologist and educator at Columbia University, where he is professor of medicine at the Vagelos College of Physicians and Surgeons, professor of epidemiology at the Mailman School of Public Health, and Dean Emeritus of the Faculties of Health Sciences and Medicine. From 2006 to 2020 he served as Executive Vice President and Dean of the Faculties of Health Sciences and Medicine, Chief Executive Officer of the Columbia University Irving Medical Center, and Harold and Margaret Hatch Professor of the university. Before moving to Columbia, he was chair of the department of medicine at the University of California, San Francisco. He received his B.A., M.D., and M.P.H. degrees from Yale University.

References

  1. ↑ Goldman, L.; Caldera, D. L.; Nussbaum, S. R.; Southwick, F. S.; Krogstad, D.; Murray, B.; Burke, D. S.; O'Malley, T. A.; Goroll, A. H.; Caplan, C. H.; Nolan, J.; Carabello, B.; Slater, E. E. (1977). "Multifactorial Index of Cardiac Risk in Noncardiac Surgical Procedures". New England Journal of Medicine. 297 (16): 845–850. doi:10.1056/NEJM197710202971601. PMID   904659.
  2. ↑ Lee, T. H.; Marcantonio, E. R.; Mangione, C. M.; Thomas, E. J.; Polanczyk, C. A.; Cook, E. F.; Sugarbaker, D. J.; Donaldson, M. C.; Poss, R.; Ho, K. K.; Ludwig, L. E.; Pedan, A.; Goldman, L. (1999). "Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery" (PDF). Circulation. 100 (10): 1043–1049. doi: 10.1161/01.CIR.100.10.1043 . PMID   10477528.
  3. ↑ Fleisher, L. A.; Beckman, J. A.; Brown, K. A.; Calkins, H.; Chaikof, E.; Fleischmann, K. E.; Freeman, W. K.; Froehlich, J. B.; Kasper, E. K.; Kersten, J. R.; Riegel, B.; Robb, J. F.; Smith Jr, S. C.; Jacobs, A. K.; Adams, C. D.; Anderson, J. L.; Antman, E. M.; Buller, C. E.; Creager, M. A.; Ettinger, S. M.; Faxon, D. P.; Fuster, V.; Halperin, J. L.; Hiratzka, L. F.; Hunt, S. A.; Lytle, B. W.; Nishimura, R.; Ornato, J. P.; Page, R. L.; Riegel, B. (2007). "ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary". Journal of the American College of Cardiology. 50 (17): 1707–1732. doi: 10.1016/j.jacc.2007.09.001 . PMID   17950159.
  4. ↑ Fleisher, Lee A.; Fleischmann, Kirsten E.; Auerbach, Andrew D.; Barnason, Susan A.; Beckman, Joshua A.; Bozkurt, Biykem; Davila-Roman, Victor G.; Gerhard-Herman, Marie D.; Holly, Thomas A. (2014). "2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery". Journal of the American College of Cardiology. 64 (22): e77–e137. doi: 10.1016/j.jacc.2014.07.944 . PMID   25091544.
  5. ↑ Onishchenko, Dmytro; Rubin, Daniel S.; van Horne, James R.; Ward, R. Parker; Chattopadhyay, Ishanu (2022-08-02). "Cardiac Comorbidity Risk Score: Zero‐Burden Machine Learning to Improve Prediction of Postoperative Major Adverse Cardiac Events in Hip and Knee Arthroplasty". Journal of the American Heart Association. 11 (15): e023745. doi:10.1161/JAHA.121.023745. PMC   9375497 . PMID   35904198.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.